Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only.
- Positions
- 24
- No filing for Q3 2021
- Portfolio value
- $350.2M
- No filing for Q3 2021
Paradigm Biocapital Advisors LP did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 260,115 | $38.2M | 10.9% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 218,158 | $29.3M | 8.4% | – | – | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 300,434 | $25.3M | 7.2% | – | – | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,209,051 | $23.9M | 6.8% | – | – | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 251,777 | $23.4M | 6.7% | – | – | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 780,480 | $22.8M | 6.5% | – | – | History |
| ARVNArvinas, Inc. | COM | 268,519 | $22.1M | 6.3% | – | – | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 385,967 | $18.0M | 5.1% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 844,005 | $16.1M | 4.6% | – | – | History |
| SGENSeagen Inc. | COM | 100,687 | $15.6M | 4.4% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 42,050 | $14.7M | 4.2% | – | – | History |
| ISEEIVERIC bio, Inc. | COM | 815,581 | $13.6M | 3.9% | – | – | History |
| INSMINSMED Inc | COM PAR $.01 | 394,358 | $10.7M | 3.1% | – | – | History |
| SRRASierra Oncology, Inc. | COM NEW | 474,945 | $10.3M | 2.9% | – | – | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 453,091 | $9.92M | 2.8% | – | – | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 167,824 | $9.25M | 2.6% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 258,746 | $8.33M | 2.4% | – | – | History |
| KYMRKymera Therapeutics, Inc. | COM | 125,858 | $7.99M | 2.3% | – | – | History |
| VORVor Biopharma Inc. | COM | 629,342 | $7.31M | 2.1% | – | – | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 75,507 | $5.65M | 1.6% | – | – | History |
| OYSTOyster Point Pharma, Inc. | COM | 304,238 | $5.55M | 1.6% | – | – | History |
| IMCRImmunocore Holdings plc | ADS | 134,249 | $4.60M | 1.3% | – | – | History |
| ESPREsperion Therapeutics, Inc. | COM | 839,257 | $4.20M | 1.2% | – | – | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 545,388 | $3.29M | 0.9% | – | – | – |